Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

FLJ39639 Inhibitors

FLJ39639 inhibitors are a class of chemical compounds designed to target the FLJ39639 gene product, which encodes for a protein of interest in various biochemical pathways. These inhibitors function by interacting directly or indirectly with the protein, modulating its activity at a molecular level. The exact mechanism of action can vary between inhibitors but generally involves binding to key functional domains of the protein, such as active sites or allosteric regions, which can either block or enhance specific interactions or reactions. Such inhibition is often employed in biochemical research to elucidate the role of FLJ39639 in cellular processes, including its involvement in signal transduction, metabolic pathways, or protein-protein interactions.

Structurally, FLJ39639 inhibitors may belong to a variety of chemical families, with their design often focused on optimizing binding affinity, specificity, and stability in experimental conditions. Researchers utilize techniques such as high-throughput screening and structure-activity relationship (SAR) studies to refine these inhibitors, ensuring they selectively affect the FLJ39639 protein without significant off-target effects. This selectivity is critical for studying the protein's function in isolation, as well as understanding its interactions with other biomolecules. The chemical composition of these inhibitors often features moieties that enable them to penetrate cells and reach intracellular targets, which is crucial for in vitro and in vivo research. Overall, these inhibitors serve as valuable tools for investigating the molecular biology associated with FLJ39639.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A potent PI3K inhibitor, can prevent phosphorylation events required for signal transduction pathways that FLJ39639 may be part of.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$104.00
$141.00
14
(1)

Specifically inhibits Akt, which can alter downstream signaling affecting FLJ39639 if it is an Akt pathway participant.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, can modulate stress responses and apoptosis, potentially impacting FLJ39639 function if involved in these processes.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$47.00
$143.00
$680.00
16
(1)

FGFR inhibitor, can block growth factor signaling that may regulate FLJ39639 if it is associated with growth factor-mediated pathways.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor, can affect the degradation of proteins, potentially impacting levels of FLJ39639 if it is regulated by proteasomal degradation.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

Inhibits Wnt production, can alter Wnt signaling pathway and potentially FLJ39639 activity if it is part of this pathway.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

A broad-spectrum protein kinase C inhibitor, can mediate signal transduction impacting FLJ39639 if it is regulated by PKC.

BML-275

866405-64-3sc-200689
sc-200689A
5 mg
25 mg
$96.00
$355.00
69
(1)

AMPK inhibitor, can disrupt energy homeostasis and signaling, potentially affecting FLJ39639 if it interacts with the AMPK pathway.

CX-4945

1009820-21-6sc-364475
sc-364475A
2 mg
50 mg
$183.00
$800.00
9
(2)

Inhibits CK2, can modulate various signaling pathways and cellular processes, possibly affecting FLJ39639 if CK2 signaling influences it.

BIX 02189

1094614-85-3sc-364436
sc-364436A
5 mg
10 mg
$224.00
$386.00
5
(1)

MEK5 inhibitor, can affect the ERK5 pathway and potentially impact FLJ39639 if it is part of this signaling cascade.